FocusCancer

Small cell lung cancer: Time to revisit DNA-damaging chemotherapy

See allHide authors and affiliations

Science Translational Medicine  06 Jul 2016:
Vol. 8, Issue 346, pp. 346fs12
DOI: 10.1126/scitranslmed.aaf6282

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Rational use of DNA-damaging chemotherapy, with new combinations to heighten DNA replication stress, could improve outcomes in small cell lung cancer.

View Full Text